As 2022 drew to a close, Siemens Healthineers announced that it would be embarking on a yearslong cost-cutting campaign within its diagnostics division that would include swaths of layoffs and a slimmed-down product portfolio. The medtech giant still hasn’t disclosed the total number of positions that will be affected by the layoffs, but several dozen are now on the chopping block in New Jersey.

While many wearable devices currently available to people with Parkinson’s disease focus mainly on tracking the condition, the latest iteration of Cala Health’s externally worn technology is aiming to effectively treat the tremors associated with the disease.

Coherus is doubling down on its immuno-oncology pipeline with a $65 million deal to buy Surface Oncology.

BearCare has issued a voluntary recall of a wearable thermometer product after reports of “minor to severe” skin burns and irritation with the device.

Hello again to a monovalent COVID-19 vaccine. Goodbye to the bivalent shot. That was the message Thursday from an FDA advisory committee, which decided unanimously that COVID vaccines this fall should not provide coverage against the original, wild-type coronavirus and that protection only is needed against an XBB strain.

Transcranial magnetic stimulation pioneer Neuronetics has picked up a new FDA clearance that builds its position in obsessive compulsive disorder (OCD), a major new application of the technology.